Bob Huang
Direktor/Vorstandsmitglied bei Travecta Therapeutics Pte Ltd.
Profil
Bob Huang is currently the Director at Travecta Therapeutics Pte Ltd.
and Investment Director at Seidler Equity Australia.
He holds a doctorate from The University of New South Wales and an MBA from The Wharton School of the University of Pennsylvania.
Aktive Positionen von Bob Huang
| Unternehmen | Position | Beginn |
|---|---|---|
| Seidler Equity Australia | Private Equity Investor | 01.01.2017 |
Travecta Therapeutics Pte Ltd.
 Travecta Therapeutics Pte Ltd. Packaged SoftwareTechnology Services Travecta Therapeutics Pte Ltd. develops a novel chemistry platform for delivery of therapies to the brain. The company was founded by David L. Silver, Mahmood Ahmed, Michael Shleifer and Laurent Benissan and is headquartered in Singapore. | Direktor/Vorstandsmitglied | 27.10.2021 |
Ausbildung von Bob Huang
| The University of New South Wales | Doctorate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Travecta Therapeutics Pte Ltd.
Travecta Therapeutics Pte Ltd. Packaged SoftwareTechnology Services Travecta Therapeutics Pte Ltd. develops a novel chemistry platform for delivery of therapies to the brain. The company was founded by David L. Silver, Mahmood Ahmed, Michael Shleifer and Laurent Benissan and is headquartered in Singapore. | Technology Services |
| Seidler Equity Australia | Finance |